Trial Profile
The pharmacokinetics and safety of this novel formulation of abiraterone acetate (DRGT 45) in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Aug 2021
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Pharmacokinetics
- 20 Dec 2017 New trial record